APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection
Links shared publicly online about this topic.
- 153total visits
APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA)
View full resource at medicalnewstoday.com
Tags: High Blood Pressure Medication, Diet and Nutrition, Drug, Pharma, FDA, Catapres
Most Recently Shared on July 12, 2011 at 7:06 am By:
APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection http://mnt.to/3Y8L #regulatory
Also Shared By:
Advertisement
MNT Pain News
@mnt_pain
APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection http://mnt.to/3Y8L #pain
1 year ago...